AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glopride M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Globela Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glopride M 1mg/500mg Tablet ER

Metformin/Glimepiride extended-release tablets (1mg/500mg) are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your glycemic control. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose, potentially causing kidney impairment, vision loss, neuropathy, and limb complications. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glopride M 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glopride M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glopride M 1mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Glopride M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glopride M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glopride M 1mg/500mg Extended-Release tablet whole; do not break, crush, or chew it. Administer this medicine with a meal.

How Glopride M 1mg/500mg Tablet ER works:

Glopride M Extended-Release tablets (1mg/500mg) contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glopride M 1mg/500mg Extended-Release tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glopride M tablets (1mg/500mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glopride M tablets (1mg/500mg) are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms appear.

KidneyKidneyCAUTION

Exercise caution when administering Glopride M 1mg/500mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glopride M 1mg/500mg Extended-Release tablets. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glopride M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical consultation is advised. For those with mild to moderate liver disease, Glopride M 1mg/500mg Extended-Release tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glopride M 1mg/500mg Tablet ER :

Should you forget a dose of Glopride M 1mg/500mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glopride M 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glopride M 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it's inaccessible to children, pets, and others.
Glopride M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention and discontinue Glopride M 1mg/500mg Tablet ER if these symptoms occur.
Glopride M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glopride M 1mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glopride M 1mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glopride M 1mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glopride M 1mg/500mg Tablet ER and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glopride M 1mg/500mg Tabl...
38
MRP 44
13% off